ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammerschlag, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammerschlag, M.
Eur Respir J 2000; 16: 1001-1007
Copyright © ERS Journals Ltd 2000


Original Articles

Chlamydia pneumoniae and the lung

MR Hammerschlag

Chlamydia pneumoniae is a frequently occurring respiratory pathogen affecting all age groups. It may cause 5-20% of community-acquired pneumonias in adults and children. The organism has also been implicated as an infectious trigger for asthma. Furthermore, new studies suggest that it may play a role in the pathogenesis of several chronic diseases including atherosclerosis. However, despite the growing significance of C. pneumoniae as a pathogen, progress is hampered by the lack of standardized diagnostic methods including serology and polymerase chain reaction. This makes it practically impossible for the practitioner to make a specific microbiological diagnosis. The lack of standardized methods has also had an adverse effect on treatment trials. The dependence on serology for diagnosis in treatment studies has generated some questionable results. Unless cultures are performed, microbiological efficacy cannot be assessed and it may never be possible to survey for or document the emergence of resistance.


This article has been cited by other articles:


Home page
CVIHome page
N. Miyashita, K. Ouchi, F. Kishi, M. Tabuchi, N. Tsumura, H. Bannai, S. Iwata, T. Tanaka, and M. Oka
Rapid and Simple Diagnosis of Chlamydophila pneumoniae Pneumonia by an Immunochromatographic Test for Detection of Immunoglobulin M Antibodies
Clin. Vaccine Immunol., July 1, 2008; 15(7): 1128 - 1131.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Apfalter
Chlamydia pneumoniae, Stroke, and Serological Associations: Anything Learned From the Atherosclerosis-Cardiovascular Literature or Do We Have to Start Over Again?
Stroke, March 1, 2006; 37(3): 756 - 758.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. J. Littman, L. A. Jackson, and T. L. Vaughan
Chlamydia pneumoniae and Lung Cancer: Epidemiologic Evidence
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 773 - 778.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Hermann, K. Gueinzius, A. Oehme, S. von Aulock, E. Straube, and T. Hartung
Comparison of Quantitative and Semiquantitative Enzyme-Linked Immunosorbent Assays for Immunoglobulin G against Chlamydophila pneumoniae to a Microimmunofluorescence Test for Use with Patients with Respiratory Tract Infections
J. Clin. Microbiol., June 1, 2004; 42(6): 2476 - 2479.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the European Respiratory Society.